# Infectious Disease Agents - Antivirals – HIV 

[Criteria Document](https://mygainwell-my.sharepoint.com/:w:/g/personal/kaelyn_dobbins_gainwelltechnologies_com/EfQXBScfWulIhXgPmaEqpHwB8e51967UykrdYfStY3qIkQ?e=doh37f){:target="_blank" rel="noopener}

|||
| ---------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Criteria 1 | NP - Abacavir Susp, Abacavir/Lamivudine/Zidovudine, Aptivus, Didanosine, Edurant, Fosamprenavir, Fuzeon, Lamivudine Tab, Lamivudine/Zidovudine, Nevirapine IR, Nevirapine ER Tab, Norvir Powder, Norvir Sol, Stavudine, Stribild, Tybost, Viracept |
| Criteria 2 | NP with AR- Lamivudine Sol, Nevirapine Sol                                                                                                                                                                                                         |
| Criteria 3 | Agents with BvG- Efavirenz/Lamivudine/Tenofovir Disoproxil Fumarate, Selzentry, Maraviroc, Intelence, Etravirine, Emtricitabine, Darunavir                                                                                                         |
| Criteria 4 | Isentress Chew Tab (P, AR)                                                                                                                                                                                                                         |
| Criteria 5 | Triumeq PD (P, PA)                                                                                                                                                                                                                                 |
| Criteria 6 | Rukobia ER (P, PA)                                                                                                                                                                                                                                 |

## Non-Preferred Products

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong> </th>
<th>Infectious Disease Agents: Antivirals – HIV</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Non-Preferred Products</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td>GCNSeqNo </td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td>X</td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code (s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
</tr>
<tr class="even">
<td></td>
<td>ABACAVIR SUSP</td>
<td>040965</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ABACAVIR/LAMIVUDINE/ZIDOVUDINE</td>
<td>047121</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>APTIVUS</td>
<td>059306</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>DIDANOSINE</td>
<td>046738</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>DIDANOSINE</td>
<td>046739</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>EDURANT</td>
<td>067413</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FOSAMPRENAVIR</td>
<td>053176</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FOSAMPRENAVIR</td>
<td>058365</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FUZEON</td>
<td>068664</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>LAMIVUDINE TAB</td>
<td>041033</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>LAMIVUDINE TAB</td>
<td>024417</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>LAMIVUDINE TAB</td>
<td>049905</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>LAMIVUDINE/ZIDOVUDIN</td>
<td>034186</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>NEVIRAPINE IR, ER TAB</td>
<td>027467</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>NEVIRAPINE IR, ER TAB</td>
<td>067250</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>NEVIRAPINE IR, ER TAB</td>
<td>068203</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>NORVIR POWDER, SOL</td>
<td>025080</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>NORVIR POWDER, SOL</td>
<td>075279</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>STAVUDINE</td>
<td>021982</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>STAVUDINE</td>
<td>021983</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>STAVUDINE</td>
<td>021985</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>STRIBILD</td>
<td>069883</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>TYBOST</td>
<td>072318</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>VIRACEPT</td>
<td>030366</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>VIRACEPT</td>
<td>052160</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number </strong></th>
<th><strong>Question ID </strong></th>
<th><strong>Default Next Question ID </strong></th>
<th><strong>Question Type </strong></th>
<th><strong>Question Text </strong></th>
<th><strong>Choice Text </strong></th>
<th><strong>Next Question ID </strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1 </td>
<td>0997</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the patient taken the drug in the previous 120 days?</p>
<p>If yes, please submit documentation of recent use.</p></td>
<td>Y</td>
<td>END (Approve x 365 Days)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0998</td>
</tr>
<tr class="odd">
<td>2</td>
<td>0998</td>
<td></td>
<td>Select </td>
<td><p>Is the patient new to therapy (initial authorization request) or continuing therapy (re-authorization request)?  </p>
<p>  </p></td>
<td>New Start (initial authorization request)</td>
<td>0999</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request)  </td>
<td>1234</td>
</tr>
<tr class="odd">
<td>3</td>
<td>0999</td>
<td></td>
<td>Select </td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?  </td>
<td>Y </td>
<td>1000</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>4</td>
<td>1000 </td>
<td> </td>
<td>Select and Free Text</td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">30 days</span> with at least <span class="underline">one preferred</span> drug?</p>
<p>If yes, please submit the medication trials and dates. If applicable, the request must address the inability to use the individual components.</p></td>
<td>Y </td>
<td>1002</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1001</td>
</tr>
<tr class="odd">
<td>5</td>
<td>1001</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances)?</p>
<p>If yes, please submit the medication name and reason for inability to use. </p></td>
<td>Y   </td>
<td>1002</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N   </td>
<td>1236 </td>
</tr>
<tr class="odd">
<td>6</td>
<td>1002</td>
<td></td>
<td>Select</td>
<td><p>Is the request for any of the following:</p>
<p>1) a nonsolid oral dosage formulation</p>
<p>2) a non-preferred extended release formulation</p>
<p>3) a non-preferred brand name that has a preferred generic product</p></td>
<td>Y</td>
<td>1003</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>END (Approve x 365 Days)</td>
</tr>
<tr class="odd">
<td>7</td>
<td>1003</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of medical necessity for the requested product (i.e. medical reasons for why the patient cannot be changed to a solid oral dosage formulation, inadequate clinical response with a product’s immediate release formulation, or inadequate clinical response or allergy of two or more generic labelers)?</td>
<td>Y</td>
<td>END (Approve x 365 Days)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>8</td>
<td>1234</td>
<td></td>
<td>Select and Free Text  </td>
<td>Has the provider submitted documentation of the patient’s clinical response to treatment and ongoing safety monitoring?</td>
<td>Y</td>
<td>END (Approve x 365 Days)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td> N    </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>9</td>
<td>1235</td>
<td></td>
<td>Free Text</td>
<td>Please provide the rationale for the medication being requested. </td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
<tr class="even">
<td>10</td>
<td>1236</td>
<td></td>
<td>Free Text</td>
<td>Please explain the reason(s) why the patient is unable to use medications not requiring prior approval.</td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS: 365 Days

|||
| ------------------ | --------- |
| **Last Approved ** | 8/18/2023 |
| **Other**          |           |

## Lamivudine Sol, Nevirapine Sol

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong> </th>
<th>Infectious Disease Agents: Antivirals – HIV</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Lamivudine Sol, Nevirapine Sol</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td>GCNSeqNo </td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td>X</td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code (s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
</tr>
<tr class="even">
<td></td>
<td>LAMIVUDINE SOL</td>
<td>041032</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>LAMIVUDINE SOL</td>
<td>024418</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>NEVIRAPINE SOL</td>
<td>040786</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number </strong></th>
<th><strong>Question ID </strong></th>
<th><strong>Default Next Question ID </strong></th>
<th><strong>Question Type </strong></th>
<th><strong>Question Text </strong></th>
<th><strong>Choice Text </strong></th>
<th><strong>Next Question ID </strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1 </td>
<td>0997</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the patient taken the drug in the previous 120 days?</p>
<p>If yes, please submit documentation of recent use.</p></td>
<td>Y</td>
<td>END (Approve x 365 Days)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0998</td>
</tr>
<tr class="odd">
<td>2</td>
<td>0998</td>
<td></td>
<td>Select </td>
<td><p>Is the patient new to therapy (initial authorization request) or continuing therapy (re-authorization request)?  </p>
<p>  </p></td>
<td>New Start (initial authorization request)</td>
<td>0999</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request)  </td>
<td>1234</td>
</tr>
<tr class="odd">
<td>3</td>
<td>0999</td>
<td></td>
<td>Select </td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?  </td>
<td>Y </td>
<td>1000</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>4</td>
<td>1000 </td>
<td> </td>
<td>Select and Free Text</td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">30 days</span> with at least <span class="underline">one preferred</span> drug?</p>
<p>If yes, please submit the medication trials and dates. If applicable, the request must address the inability to use the individual components.</p></td>
<td>Y </td>
<td>1002</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1001</td>
</tr>
<tr class="odd">
<td>5</td>
<td>1001</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances)?</p>
<p>If yes, please submit the medication name and reason for inability to use. </p></td>
<td>Y   </td>
<td>1002</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N   </td>
<td>1236 </td>
</tr>
<tr class="odd">
<td>6</td>
<td>1002</td>
<td></td>
<td>Select</td>
<td><p>Is the request for any of the following:</p>
<p>1) a nonsolid oral dosage formulation</p>
<p>2) a non-preferred extended release formulation</p>
<p>3) a non-preferred brand name that has a preferred generic product</p></td>
<td>Y</td>
<td>1003</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1004</td>
</tr>
<tr class="odd">
<td>7</td>
<td>1003</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of medical necessity for the requested product (i.e. medical reasons for why the patient cannot be changed to a solid oral dosage formulation, inadequate clinical response with a product’s immediate release formulation, or inadequate clinical response or allergy of two or more generic labelers)?</td>
<td>Y</td>
<td>1004</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>8</td>
<td>1004</td>
<td></td>
<td>Select</td>
<td>Is the patient 3 years of age and older?</td>
<td>Y</td>
<td>1235</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>END (Approve x 365 days)</td>
</tr>
<tr class="odd">
<td>9</td>
<td>1234</td>
<td></td>
<td>Select and Free Text  </td>
<td><p>Has the provider submitted documentation of the patient’s clinical response to treatment and ongoing safety monitoring?</p>
<p> </p></td>
<td>Y</td>
<td>END (Approve x 365 Days)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td> N    </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>10</td>
<td>1235</td>
<td></td>
<td>Free Text</td>
<td>Please provide the rationale for the medication being requested. </td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
<tr class="even">
<td>11</td>
<td>1236</td>
<td></td>
<td>Free Text</td>
<td>Please explain the reason(s) why the patient is unable to use medications not requiring prior approval.</td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS: 365 Days

|||
| ------------------ | --------- |
| **Last Approved ** | 8/18/2023 |
| **Other**          |           |

## Non-Preferred Products with BvG

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong> </th>
<th>Infectious Disease Agents: Antivirals – HIV</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Non-Preferred Products with BvG</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td>GCNSeqNo </td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td>X</td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code (s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
</tr>
<tr class="even">
<td></td>
<td>EFAVIRENZ/LAMIVUDINE/TENOFOVIR DISOPROXIL FUMARATE</td>
<td>078145</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>EFAVIRENZ/LAMIVUDINE/TENOFOVIR DISOPROXIL FUMARATE</td>
<td>078254</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>SELZENTRY</td>
<td>062974</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>SELZENTRY</td>
<td>062979</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>SELZENTRY</td>
<td>076850</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>SELZENTRY</td>
<td>077086</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>SELZENTRY</td>
<td>077087</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MARAVIROC</td>
<td>062974</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MARAVIROC</td>
<td>062979</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>INTELENCE</td>
<td>063597</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>INTELENCE</td>
<td>066982</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>INTELENCE</td>
<td>069091</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ETRAVIRINE</td>
<td>063597</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ETRAVIRINE</td>
<td>066982</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>EMTRICITABINE</td>
<td>052802</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>DARUNAVIR</td>
<td>063719</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>DARUNAVIR</td>
<td>070245</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number </strong></th>
<th><strong>Question ID </strong></th>
<th><strong>Default Next Question ID </strong></th>
<th><strong>Question Type </strong></th>
<th><strong>Question Text </strong></th>
<th><strong>Choice Text </strong></th>
<th><strong>Next Question ID </strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1 </td>
<td>0997</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the patient taken the drug in the previous 120 days?</p>
<p>If yes, please submit documentation of recent use.</p></td>
<td>Y</td>
<td>END (Approve x 365 Days)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0998</td>
</tr>
<tr class="odd">
<td>2</td>
<td>0998</td>
<td></td>
<td>Select </td>
<td>Is the patient new to therapy (initial authorization request) or continuing therapy (re-authorization request)?  </td>
<td>New Start (initial authorization request)</td>
<td>0999</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request)  </td>
<td>1234</td>
</tr>
<tr class="odd">
<td>3</td>
<td>0999</td>
<td></td>
<td>Select </td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?  </td>
<td>Y </td>
<td>1000</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>4</td>
<td>1000 </td>
<td> </td>
<td>Select and Free Text</td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">30 days</span> with at least <span class="underline">one preferred</span> drug?</p>
<p>If yes, please submit the medication trials and dates. If applicable, the request must address the inability to use the individual components.</p></td>
<td>Y </td>
<td>1002</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1001</td>
</tr>
<tr class="odd">
<td>5</td>
<td>1001</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances)?</p>
<p>If yes, please submit the medication name and reason for inability to use. </p></td>
<td>Y   </td>
<td>1002</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N   </td>
<td>1236 </td>
</tr>
<tr class="odd">
<td>6</td>
<td>1002</td>
<td></td>
<td>Select</td>
<td><p>Is the request for any of the following:</p>
<p>1) a nonsolid oral dosage formulation</p>
<p>2) a non-preferred extended release formulation</p>
<p>3) a non-preferred brand name that has a preferred generic product</p></td>
<td>Y</td>
<td>1003</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1004</td>
</tr>
<tr class="odd">
<td>7</td>
<td>1003</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of medical necessity for the requested product (i.e. medical reasons for why the patient cannot be changed to a solid oral dosage formulation, inadequate clinical response with a product’s immediate release formulation, or inadequate clinical response or allergy of two or more generic labelers)?</td>
<td>Y</td>
<td>1004</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>8</td>
<td>1004</td>
<td></td>
<td>Select</td>
<td>Which medication is being requested?</td>
<td>Generic efavirenz/lamivudine/tenofovir disoproxil fumarate</td>
<td>1005</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Brand Selzentry</td>
<td>END (Approve x 365 Days)</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Generic maraviroc</td>
<td>1005</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Brand Intelence</td>
<td>END (Approve x 365 Days)</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Generic etravirine</td>
<td>1005</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Generic emtricitabine</td>
<td>1005</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Generic darunavir</td>
<td>1005</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Other</td>
<td>END (Approve x 365 days)</td>
</tr>
<tr class="odd">
<td>9</td>
<td>1005</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the brand medication been attempted and failed or is the brand medication contraindicated?  </p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>END (Approve x 365 Days)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>10</td>
<td>1234</td>
<td></td>
<td>Select and Free Text  </td>
<td><p>Has the provider submitted documentation of the patient’s clinical response to treatment and ongoing safety monitoring?</p>
<p> </p></td>
<td>Y    </td>
<td>END (Approve x 365 Days)  </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td> N    </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>11</td>
<td>1235</td>
<td></td>
<td>Free Text</td>
<td>Please provide the rationale for the medication being requested. </td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
<tr class="even">
<td>12</td>
<td>1236</td>
<td></td>
<td>Free Text</td>
<td>Please explain the reason(s) why the patient is unable to use medications not requiring prior approval.</td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS: 365 Days

|||
| ------------------ | --------- |
| **Last Approved ** | 8/18/2023 |
| **Other**          |           |

## Isentress Chew Tab

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong> </th>
<th>Infectious Disease Agents: Antivirals – HIV</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Isentress Chew Tab</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td>GCNSeqNo </td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th>X</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td></td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code (s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
</tr>
<tr class="even">
<td></td>
<td>ISENTRESS CHEW TAB</td>
<td>068332</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ISENTRESS CHEW TAB</td>
<td>068334</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

| **Sequence Number ** | **Question ID ** | **Default Next Question ID ** | **Question Type ** | **Question Text **                                               | **Choice Text **            | **Next Question ID ** |
| -------------------- | ---------------- | ----------------------------- | ------------------ | ---------------------------------------------------------------- | --------------------------- | --------------------- |
| 1                    | 1234             |                               | Select             | Is the patient 12 years of age and older?                        | Y                           | 1235                  |
|                      |                  |                               |                    |                                                                  | N                           | 1236                  |
| 2                    | 1235             |                               | Free Text          | Please provide the rationale for the medication being requested. | END (Pending Manual Review) |                       |
| 3                    | 1236             |                               | Free Text          | A PA is not required for those younger than 12 years of age.     | END (Pending Manual Review) |                       |

LENGTH OF AUTHORIZATIONS: 365 Days

|||
| ------------------ | --------- |
| **Last Approved ** | 8/18/2023 |
| **Other**          |           |

## Triumeq PD

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong> </th>
<th>Infectious Disease Agents: Antivirals – HIV</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Triumeq PD</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td>GCNSeqNo </td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th>X</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td></td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code (s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
</tr>
<tr class="even">
<td></td>
<td>TRIUMEQ PD</td>
<td>083242</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number </strong></th>
<th><strong>Question ID </strong></th>
<th><strong>Default Next Question ID </strong></th>
<th><strong>Question Type </strong></th>
<th><strong>Question Text </strong></th>
<th><strong>Choice Text </strong></th>
<th><strong>Next Question ID </strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1 </td>
<td>0996</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the patient taken the drug in the previous 120 days?</p>
<p>If yes, please submit documentation of recent use.</p></td>
<td>Y</td>
<td>END (Approve x 365 Days)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0997</td>
</tr>
<tr class="odd">
<td>2</td>
<td>0997</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the patient’s weight?</p>
<p>Please note: This medication will only be authorized for those 10 – 25 kg.</p></td>
<td>Y</td>
<td>0998</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>3</td>
<td>0998</td>
<td></td>
<td>Select </td>
<td><p>Is the patient new to therapy (initial authorization request) or continuing therapy (re-authorization request)?  </p>
<p>  </p></td>
<td>New Start (initial authorization request)</td>
<td>0999</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request)  </td>
<td>1234</td>
</tr>
<tr class="odd">
<td>4</td>
<td>0999</td>
<td></td>
<td>Select </td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?  </td>
<td>Y </td>
<td>END (Approve x 365 Days)  </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>5</td>
<td>1234</td>
<td></td>
<td>Select and Free Text  </td>
<td>Has the provider submitted documentation of the patient’s clinical response to treatment and ongoing safety monitoring?</td>
<td> Y    </td>
<td>END (Approve x 365 Days)   </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td> N    </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>6</td>
<td>1235</td>
<td></td>
<td>Free Text</td>
<td>Please provide the rationale for the medication being requested. </td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS: 365 Days

|||
| ------------------ | --------- |
| **Last Approved ** | 8/18/2023 |
| **Other**          |           |

## Rukobia ER

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong> </th>
<th>Infectious Disease Agents: Antivirals – HIV</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Rukobia ER</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td>GCNSeqNo </td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th>X</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td></td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code (s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
</tr>
<tr class="even">
<td></td>
<td>RUKOBIA ER</td>
<td>081260</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

| **Sequence Number ** | **Question ID ** | **Default Next Question ID ** | **Question Type ** | **Question Text **                                                                                        | **Choice Text **            | **Next Question ID **    |
| -------------------- | ---------------- | ----------------------------- | ------------------ | --------------------------------------------------------------------------------------------------------- | --------------------------- | ------------------------ |
| 1                    | 1234             |                               | Select             | Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling? | Y                           | END (Approve x 365 days) |
|                      |                  |                               |                    |                                                                                                           | N                           | 1235                     |
| 2                    | 1235             |                               | Free Text          | Please provide the rationale for the medication being requested.                                          | END (Pending Manual Review) |                          |

LENGTH OF AUTHORIZATIONS: 365 Days

|||
| ------------------ | --------- |
| **Last Approved ** | 8/18/2023 |
| **Other**          |           |
